These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11041231)

  • 21. Endometrial biopsy collection from women receiving Norplant.
    Hadisaputra W; Affandi B; Witjaksono J; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():31-4. PubMed ID: 8982743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinase-1 and -3 and mast cells are present in the endometrium of women using progestin-only contraceptives.
    Vincent AJ; Zhang J; Ostor A; Rogers PA; Affandi B; Kovacs G; Salamonsen LA
    Hum Reprod; 2000 Jan; 15(1):123-30. PubMed ID: 10611200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial epithelial integrity and subepithelial reticular fibre expression in progestin contraceptive acceptors.
    Wonodirekso S; Affandi B; Siregar B; Barasila AC; Damayanti L; Rogers PA
    Hum Reprod; 2000 Aug; 15 Suppl 3():189-96. PubMed ID: 11041235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on relationship between endometrium laminin expression and irregular uterine bleeding in Norplant users].
    Shi X; Han X; Weng J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Mar; 35(3):169-71. PubMed ID: 11775898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the endometrial changes in Norplant users.
    Wan LS
    Ann N Y Acad Sci; 1997 Sep; 828():108-10. PubMed ID: 9329828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The changes of sex steroid receptors and morphology in Norplant treated endometrium].
    Wang G; Zheng S; Fan Z
    Zhonghua Fu Chan Ke Za Zhi; 1998 Aug; 33(8):493-7. PubMed ID: 10806752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progesterone receptor in Norplant endometrium.
    Lau TM; Witjaksono J; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():90-4. PubMed ID: 8982750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of matrix metalloproteinase-26 and tissue inhibitor of matrix metalloproteinase-3 and -4 in endometrium throughout the normal menstrual cycle and alteration in users of levonorgestrel implants who experience irregular uterine bleeding.
    Chegini N; Rhoton-Vlasak A; Williams RS
    Fertil Steril; 2003 Sep; 80(3):564-70. PubMed ID: 12969699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding.
    Pritts EA; Ryan IP; Mueller MD; Lebovic DI; Shifren JL; Zaloudek CJ; Korn AP; Darney PD; Taylor RN
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2142-7. PubMed ID: 15623808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits of vitamin E supplementation to Norplant users--in vitro and in vivo studies.
    Subakir SB; Setiadi E; Affandi B; Pringgoutomo S; Freisleben HJ
    Toxicology; 2000 Aug; 148(2-3):173-8. PubMed ID: 10962136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The measurement of endometrial perfusion in norplant users: a pilot study.
    Hickey M; Carati C; Manconi F; Gannon BJ; Dwarte D; Fraser IS
    Hum Reprod; 2000 May; 15(5):1086-91. PubMed ID: 10783358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometrial expression of epithelial neutrophil-activating peptide-78 during the menstrual cycle or in progestin-only contraceptive users with breakthrough bleeding and the influence of doxycycline therapy.
    Chegini N; Luo X; Pan Q; Rhoton-Vlasak A; Archer DF
    Hum Reprod; 2007 Feb; 22(2):427-33. PubMed ID: 17095519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of irregular uterine bleeding and spotting associated with Norplant.
    Archer DF; Philput CA; Weber ME
    Hum Reprod; 1996 Oct; 11 Suppl 2():24-30. PubMed ID: 8982742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding.
    Hickey M; Dwarte D; Fraser IS
    Hum Reprod; 2000 Jul; 15(7):1509-14. PubMed ID: 10875858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and BCL-2 oncoprotein and phase-specific production of TNF alpha in human endometrium.
    Tabibzadeh S; Zupi E; Babaknia A; Liu R; Marconi D; Romanini C
    Hum Reprod; 1995 Feb; 10(2):277-86. PubMed ID: 7539446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium.
    Burton KA; Henderson TA; Hillier SG; Mason JI; Habib F; Brenner RM; Critchley HO
    Hum Reprod; 2003 Dec; 18(12):2610-7. PubMed ID: 14645180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9 (gelatinase B).
    Vincent AJ; Malakooti N; Zhang J; Rogers PA; Affandi B; Salamonsen LA
    Hum Reprod; 1999 Mar; 14(3):807-15. PubMed ID: 10221718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel.
    Rogers PA; Au CL; Affandi B
    Hum Reprod; 1993 Sep; 8(9):1396-404. PubMed ID: 8253925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium.
    Lau TM; Affandi B; Rogers PA
    Mol Hum Reprod; 1999 Jan; 5(1):57-63. PubMed ID: 10050663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.